Whitehawk Therapeutics (WHWK) Goodwill & Intangibles (2021 - 2022)

Whitehawk Therapeutics (WHWK) reported Goodwill & Intangibles of $3.7 million for Q1 2022, down 1.78% quarter-over-quarter from $3.8 million in Q4 2021.

Whitehawk Therapeutics (WHWK) Goodwill & Intangibles (2021 - 2022) Analysis & Trends

Whitehawk Therapeutics (WHWK) has 2 years of Goodwill & Intangibles data on file, last reported at $3.7 million in Q1 2022.

  • Goodwill & Intangibles for Q1 2022 came in at $3.7 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2022 was $3.7 million (changed N/A YoY), and the FY2021 annual result was $3.8 million, changed N/A from the prior year.
  • Goodwill & Intangibles slipped to $3.7 million in Q1 2022 per WHWK's latest filing, from $3.8 million in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $3.9 million in Q3 2021 and troughed at $3.7 million in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Whitehawk Therapeutics 310.18 Mn 187.14 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2022 3.74 Mn
Dec 31, 2021 3.81 Mn
Sep 30, 2021 3.88 Mn